This is a competitive renewal for our longstanding Training Program in Diabetes, Endocrinology and Metabolic Diseases. During the most recent funding cycle, about 5 postdoctoral fellows were supported each year. A total of 13 trainees working in 10 different labs have been supported. The program is designed to accommodate both Ph.D. scientists as well as physician scientists with M.D. or M.D, Ph.D. degrees, of whom most enter through the Penn Clinical Fellowship Program in Endocrinology, Diabetes and Metabolism. Of the 13 postdoctoral trainees supported by this T32 during the last period, 8 have """"""""graduated"""""""" while 5 are currently supported. One of the fellows who gave up the training grant had to do so prematurely due to an unexpected need to leave the country. Of the other seven, three have obtained independent KO8 funding and are presently Instructors in Medicine at the University of Pennsylvania School of Medicine. Two have returned to the clinic with plans to continue research following training in Clinical Endocrinology, one has obtained independent funding through the individual NRSA mechanism, and one has taken a position in private industry. We ask for a continuation of support for five fellows per year, anticipating that most fellows will receive two years of funding, though some one or three. For the next period, we request additional support to allow one of these five fellows to undertake specialized training in Clinical Epidemiology related to diabetes or endocrinology as part of a new program that integrates this training grant with the University of Pennsylvania Masters of Clinical Epidemiology Program. We also request, for the first time, sufficient funds to support three predoctoral students working in the areas of this program during their third through fifth years of graduate school. At present, there are in laboratories directed by our trainers 36 students working towards their Ph.D. theses, the majority focusing on problems relevant to the mission of this T32 and unsupported by training grants. Six (17%) are underrepresented minorities. Our 25 training faculty have primary appointments in nine Medical School Departments and consist of 15 professors, 7 associate professors, and assistant 3 professors. Six members of the training faculty are woman and one is African- American. The significant expansion in the number of mentors relates primarily to the institution of the training track in Clinical Epidemiology. However, two faculty members new to Penn have also been appointed to the training grant. Training grant faculty bring to the program expertise in p-cell development and function, hormone action, physiology, diabetic complications, genetics in humans and model organisms, transcriptional regulation, patient oriented research, epidemiology and biostatistics. This training program continues to provide superb preparation for those scientists committed to careers in research into diabetes, endocrinology and metabolism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007314-30
Application #
7881407
Study Section
Special Emphasis Panel (ZDK1-GRB-7 (M3))
Program Officer
Castle, Arthur
Project Start
1978-09-15
Project End
2011-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
30
Fiscal Year
2010
Total Cost
$233,758
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Vajravelu, Mary Ellen; De León, Diva D (2018) Genetic characteristics of patients with congenital hyperinsulinism. Curr Opin Pediatr 30:568-575
Vajravelu, Mary Ellen; Chai, Jinghua; Krock, Bryan et al. (2018) Congenital Hyperinsulinism and Hypopituitarism Attributable to a Mutation in FOXA2. J Clin Endocrinol Metab 103:1042-1047
Vajravelu, Mary Ellen; Keren, Ron; Weber, David R et al. (2018) Incidence and risk of celiac disease after type 1 diabetes: A population-based cohort study using the health improvement network database. Pediatr Diabetes 19:1422-1428
Herrera, Adriana; Vajravelu, Mary Ellen; Givler, Stephanie et al. (2018) Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide. J Clin Endocrinol Metab 103:4365-4372
Alhadeff, Amber L; Su, Zhenwei; Hernandez, Elen et al. (2018) A Neural Circuit for the Suppression of Pain by a Competing Need State. Cell 173:140-152.e15
Rickels, Michael R; Peleckis, Amy J; Dalton-Bakes, Cornelia et al. (2018) Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes. J Clin Endocrinol Metab 103:105-114
Barrosse-Antle, Mary; Su, Chang; Chen, Pan et al. (2017) A severe case of hyperinsulinism due to hemizygous activating mutation of glutamate dehydrogenase. Pediatr Diabetes 18:911-916
Remsberg, Jarrett R; Ediger, Benjamin N; Ho, Wesley Y et al. (2017) Deletion of histone deacetylase 3 in adult beta cells improves glucose tolerance via increased insulin secretion. Mol Metab 6:30-37
Rozo, Andrea V; Babu, Daniella A; Suen, PoMan A et al. (2017) Neonatal GLP1R activation limits adult adiposity by durably altering hypothalamic architecture. Mol Metab 6:748-759
Su, Zhenwei; Alhadeff, Amber L; Betley, J Nicholas (2017) Nutritive, Post-ingestive Signals Are the Primary Regulators of AgRP Neuron Activity. Cell Rep 21:2724-2736

Showing the most recent 10 out of 67 publications